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The annual number of AIDS deaths declined substantially in 
the USA following introduction of highly active antiretroviral 
therapy (HAART) in 1995, but has remained stable from 1999 
to 2004.1 There are approximately 1.0 - 1.2 million persons 
estimated to be living with HIV, of whom 25% are unaware of 
their infection and likely to have transmitted their infection 
unknowingly.1,2 Despite considerable survival benefits if 
treatment is initiated early before symptoms develop, 40% 
of patients receive their HIV diagnosis less than 12 months 
before developing AIDS.1 Early HIV diagnosis may therefore 
be of both public health and individual survival benefit. On 22 
September 2006 the United States National Center for HIV/
AIDS published revised recommendations for HIV testing 
of adults, adolescents and pregnant women to facilitate HIV 
testing as a normal part of medical practice similar to screening 
for other treatable conditions.3 HIV screening for all patients in 
US health care settings is now recommended unless the patient 
declines (i.e. ‘opt-out’ screening). Separate written consent 
for HIV testing is no longer required and general consent for 
medical care will be considered sufficient to encompass consent 
for HIV testing. Prevention counselling will not be required 
with HIV diagnostic testing or as part of HIV screening 
programmes in health care settings. The objective of the revised 
policy is to increase HIV screening of patients and pregnant 
women in health care settings to foster earlier detection of HIV 
infection, identify and counsel individuals with unrecognised 
HIV infection and link them to clinical and prevention services.
Four types of HIV testing 
In sub-Saharan Africa 24.5 million individuals are living with 
HIV,4 although studies have consistently shown that less than 
10% are aware of their HIV status.5 However, knowledge 
of HIV serostatus has been demonstrated to be associated 
with a decrease in sexual risk behaviour.5 The World Health 
Organization (WHO) and United Nations AIDS Organization 
(UNAIDS) encourage expansion of HIV testing and counselling 
as an important strategy in addressing the HIV/AIDS epidemic 
and as a means to attain fulfilment of the right to the highest 
possible level of health.6 The WHO and UNAIDS recognise four 
types of HIV testing, viz. client-initiated voluntary counselling 
and testing (VCT); diagnostic HIV testing of those with 
symptoms and signs of HIV-related disease; routine health care 
provider-initiated testing; and mandatory screening of blood 
destined for transfusion or manufacture of blood products. 
Substantial increases in HIV testing were observed in Botswana 
following introduction of routine health care provider-initiated 
‘opt-out’ screening in prenatal and other health care settings 
during 2004.7 A population-based study 11 months after 
introduction of the ‘opt-out’ strategy showed the policy to be 
widely supported, however concerns that the policy could 
decrease health-seeking behaviour were not demonstrated.8 
In Zimbabwe, a country with high antenatal prevalence, 45% 
of women attending 2 rural postnatal services had not been 
tested for HIV during pregnancy; of these, 80% would have 
accepted testing if an ‘opt-out’ policy had been instituted.9 The 
introduction of a routine health care provider-initiated ‘opt-out’ 
strategy for HIV testing may therefore have far-reaching public 
health and individual benefits, particularly in high prevalence 
settings.
The risk/benefit ratio of HIV testing
An estimated 5.5 million individuals live with HIV/AIDS 
in South Africa and national antenatal HIV seroprevalence 
continues to rise. Despite increasing HIV prevalence, access to 
HIV testing services continues to be poorly utilised. National 
surveys have reported low uptake of VCT services, with only 
a modest increase in utilisation from 20% to 30% between 2002 
and 2005.10,11 In addition, those individuals not seeking VCT in 
high-prevalence populations in South Africa may have equally 
high sexual risk behaviour as those seeking testing.12 Health 
care provider-initiated HIV testing in South Africa is considered 
distinct from all other routine medical testing. An HIV test is 
considered ‘a prima facie interference with a person’s right to 
freedom and security of the person and his/her privacy’, and is 
to be performed after pre-test counselling is done and specific 
written consent is given.13 Health care-initiated testing has not 
been available at all primary care facilities in South Africa,14 
the majority of medical staff have not been trained in pre-test 
counselling, and time constraints result in many missed HIV-
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testing opportunities. The ‘exceptionalisation’ of HIV testing 
developed during an earlier period of therapeutic nihilism 
when the disadvantages of testing were thought to exceed 
the benefits of testing. A positive HIV diagnosis was known 
to impact negatively on quality of life15 but the therapeutic 
benefits accruing from knowledge of HIV status were limited 
and the preventive epidemiological benefits were undefined. 
The risk/benefit ratio of HIV testing began to change with 
increasing access to the benefits of co-trimoxazole prophylaxis16 
and prevention-of-mother-to-child transmission (PMTCT) 
services. Access to antiretroviral therapy further increases 
the survival benefits conferred by knowledge of HIV-positive 
status.17 The benefit of increased population HIV testing by 
decreasing sexual risk behaviour has been demonstrated in 
the USA2 and other countries5 but has yet to be clearly shown 
within South Africa. Normalising HIV testing as part of routine 
medical care may also serve to reduce the stigma of HIV 
infection.  
As the benefits of HIV testing increase at an individual and 
population level, so HIV testing strategies need to evolve. 
The challenge we face is to maximise the benefit dividend of 
effective HIV treatment while maintaining confidentiality and 
protecting human rights. Introduction of universal ‘opt-out’ 
HIV testing in all South African health care facilities may allow 
an opportunity to fulfil the individual right to the highest 
level of health and have public health benefit by impacting on 
prevention at a population level. 
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